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In the Infiltrate
In an effort to probe the role of the 
adaptive immune system in the com-
mon chronic inflammatory skin dis-
ease rosacea, Buhl and colleagues 
utilized transcriptome analysis and 
immunohistochemistry of the inflam-
matory infiltrate from rosacea patient 
samples. These studies revealed 
that the adaptive immune system is 
broadly and significantly activated 
even in early erythematotelangiec-
tatic rosacea. The T-cell response was 
dominated by Th1/Th17 cells and substantiated by associated upregulation of 
cytokines and chemokines, and macrophages and mast cells as well as antibody-
producing plasma cells were also present in the rosacea samples. These findings 
highlight the potential for development of strategies targeting the Th1/Th17 path-
way for treatment of rosacea. See page 2198
A Good Rap
Because activation of mechanistic 
or mammalian target of rapamycin 
(mTOR) is a feature of several human 
cancers, targeting of this pathway is 
the focus of considerable research. 
Kittipongdaja and colleagues demon-
strated that treatment of T-cell lym-
phoma tumors with the mTOR inhibitor 
rapamycin suppresses tumor growth in 
mouse skin and suppresses prolifera-
tion and mTOR activity of murine and 
human T-cell lymphoma cells. Importantly, this mTOR inhibition resulted in a meta-
bolic shift with a reduced glycolytic state and continued dependence on mitochon-
drial function, counteracting the Warburg effect of cancer cells. The possibility of tar-
geting such specific metabolic pathways for therapeutic manipulation of cutaneous 
T-cell lymphoma is therefore promising. See page 2301
The Age of Collagen
Skin thinning and fragility during aging 
stem from the decline of type I col-
lagen production. In a recent study 
by Li and colleagues, prostaglandin 
E2 (PGE2), which inhibits collagen pro-
duction by fibroblasts, was elevated in 
skin fibroblasts from elderly individuals in concert with increased mRNA expression 
of prostaglandin E synthase and cyclooxygenase 2, enzymes involved in PGE2 syn-
thesis. Additionally, reduced spreading/mechanical force of fibroblasts in aging skin 
appeared to increase PGE2 production and resulted in decreased collagen produc-
tion. Thus, inhibition of PGE2 via nonsteroidal anti-inflammatory drugs may be benefi-
cial for collagen deficiency in elderly skin. See page 2181
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DC-SIGN for 
Delivery
Dendritic cell (DC) presen-
tation of antigens on major 
histocompatibility complex I 
can directly contribute to the 
induction of antitumor CD8+ 
T-cell responses. Fehres and 
colleagues used glycan-mod-
ified liposomes with encap-
sulated antigen to target 
DC-specific ICAM-3-grabbing 
nonintegrin (DC-SIGN) 
on CD14+ dermal DCs in a 
human skin explant model to 
demonstrate in situ targeting 
of these antigens. Antigen 
internalization and effective 
presentation were stimulated 
by intradermal injection of 
GM-CSF/IL-4 and resulted 
in increased antigen-specific 
CD8+ T-cell responses, sup-
porting further consideration 
of this strategy for targeted 
antitumor immunotherapy.  
See page 2228
Directing Traffic
Savinko and colleagues 
employed a mouse model 
that harbors a mutated inte-
grin regulator (kindlin-3) to 
investigate skin inflamma-
tion and the role of integrins 
in leukocyte trafficking. 
Although the integrin/kindlin 
interaction was necessary 
for trafficking of T cells and 
eosinophils into the inflamed 
skin, neutrophils were not 
dependent on this interac-
tion. Additionally, functional 
integrins played a clear anti-
inflammatory role in skin 
inflammation via restriction 
of mast cell number and 
production of IL-4, as well as 
by limiting the production 
of inflammatory, Th1, Th2, 
and Th17 cytokines in the 
inflamed skin. See page 2249
